A Randomized, Double-blind, Vehicle-controlled

Project: Research project

Description

A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 3 months in Adult Subjects with Stable Patchy Alopecia Areata
StatusActive
Effective start/end date8/1/178/30/21

Funding

  • ACLARIS THERAPEUTICS, INC

Fingerprint

Alopecia Areata
Multicenter Studies
Safety
Diffuse alopecia